[go: up one dir, main page]

DE69729469D1 - Zellbasiertes festphasentest - Google Patents

Zellbasiertes festphasentest

Info

Publication number
DE69729469D1
DE69729469D1 DE69729469T DE69729469T DE69729469D1 DE 69729469 D1 DE69729469 D1 DE 69729469D1 DE 69729469 T DE69729469 T DE 69729469T DE 69729469 T DE69729469 T DE 69729469T DE 69729469 D1 DE69729469 D1 DE 69729469D1
Authority
DE
Germany
Prior art keywords
cell
solid phase
need
based solid
phase test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69729469T
Other languages
English (en)
Other versions
DE69729469T2 (de
Inventor
Ann Brown
Ann Kasila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Health Sciences Inc
Original Assignee
NEN Life Science Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24993730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69729469(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by NEN Life Science Products Inc filed Critical NEN Life Science Products Inc
Publication of DE69729469D1 publication Critical patent/DE69729469D1/de
Application granted granted Critical
Publication of DE69729469T2 publication Critical patent/DE69729469T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Silicon Compounds (AREA)
  • Fuel Cell (AREA)
DE69729469T 1996-10-29 1997-10-29 Zellbasierter festphasenassay Expired - Lifetime DE69729469T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/744,718 US5739001A (en) 1996-10-29 1996-10-29 Solid phase cell-based assay
US744718 1996-10-29
PCT/US1997/019699 WO1998019163A1 (en) 1996-10-29 1997-10-29 A solid phase cell-based assay

Publications (2)

Publication Number Publication Date
DE69729469D1 true DE69729469D1 (de) 2004-07-15
DE69729469T2 DE69729469T2 (de) 2005-06-09

Family

ID=24993730

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729469T Expired - Lifetime DE69729469T2 (de) 1996-10-29 1997-10-29 Zellbasierter festphasenassay

Country Status (5)

Country Link
US (1) US5739001A (de)
EP (1) EP0937250B1 (de)
AT (1) ATE268904T1 (de)
DE (1) DE69729469T2 (de)
WO (1) WO1998019163A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69831522T2 (de) 1997-03-03 2006-06-14 Amersham Biosciences Uk Ltd In-situ Zellextraktion und Assay-Verfahren
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
AU4701200A (en) * 1999-05-07 2000-11-21 Quantum Dot Corporation A method of detecting an analyte using semiconductor nanocrystals
US6794156B2 (en) * 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
US6686171B2 (en) * 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
US20030157586A1 (en) * 2002-02-21 2003-08-21 Martin Bonde Device and method for conducting cellular assays using multiple fluid flow
US7785883B2 (en) * 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US8071373B2 (en) * 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US8298824B2 (en) 2004-04-28 2012-10-30 Sanofi Pasteur Vaxdesign Corporation Methods of evaluating a test agent in a diseased cell model
US7785806B2 (en) * 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US20060275270A1 (en) * 2004-04-28 2006-12-07 Warren William L In vitro mucosal tissue equivalent
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US7771999B2 (en) * 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7709256B2 (en) * 2004-04-28 2010-05-04 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7855074B2 (en) 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US20070141552A1 (en) * 2004-04-28 2007-06-21 Warren William L Automatable artificial immune system (AIS)
WO2007030521A1 (en) * 2005-09-06 2007-03-15 Invitrogen Corporation Control of chemical modification
CA2847310A1 (en) * 2005-12-21 2007-07-05 Sanofi Pasteur Vaxdesign Corporation A porous membrane device that promotes the differentiation of monocytes into dendritic cells
JP5622358B2 (ja) 2005-12-21 2014-11-12 サノフィ パスツール ヴァックスデザインコーポレーション ｉｎｖｉｔｒｏ胚中心
US7709257B2 (en) * 2006-06-27 2010-05-04 Vax Design Corp. Models for vaccine assessment
US8647837B2 (en) * 2007-07-16 2014-02-11 Sanofi Pasteur Vaxdesign Corp. Artificial tissue constructs comprising alveolar cells and methods for using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000252A (en) * 1974-01-04 1976-12-28 Kenneth Kosak Immunoscintillation cell
ES525541A0 (es) * 1982-10-12 1984-12-16 Dynatech Lab Un recipiente que tiene al menos una cavidad o pocillo para contener al menos una muestra de ensayo durante una medicion fluometrica.
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US4626513A (en) * 1983-11-10 1986-12-02 Massachusetts General Hospital Method and apparatus for ligand detection
JPS6111663A (ja) * 1984-06-28 1986-01-20 Ono Pharmaceut Co Ltd 酵素免疫測定法に用いられる酵素で標識されたロイコトリエン類
FR2615622B1 (fr) * 1987-05-19 1994-05-06 Ire Medgenix Sa Dosage plasmatique de monokines
SE8803602D0 (sv) * 1988-10-11 1988-10-11 Wallac Oy A sample plate with a plurality of sample wells or vials intended for radiolabeled binding assays
SE8804657D0 (sv) * 1988-12-27 1988-12-27 Gerald Potter Colin Support structure for use in a proximity assey
FR2679659B1 (fr) * 1991-07-23 1993-11-19 Medgenix Diagnostic Sa Procede de dosage in vitro de molecules au niveau de leur site de production par des cellules en culture et format technologique adapte.
EP0559871B1 (de) * 1991-10-01 1997-01-22 Alain Ladislas De Weck In vitro verfahren zur bestimmung in allergiediagnosen und weitere entzündungskrankheiten
ES2072847T3 (es) * 1993-05-17 1998-03-01 Amersham Int Plc Dispositivos y metodos para la medida de procesos bioquimicos celulares.

Also Published As

Publication number Publication date
EP0937250A1 (de) 1999-08-25
EP0937250B1 (de) 2004-06-09
US5739001A (en) 1998-04-14
ATE268904T1 (de) 2004-06-15
DE69729469T2 (de) 2005-06-09
WO1998019163A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
ATE268904T1 (de) Zellbasiertes festphasentest
GB2034242B (en) Enzyme-containing membrane for use in electrochemical analysis cell
DK496085D0 (da) Ruminddelt celledyrkningsindretning samt fremgangsmaade til dyrkning af celler
DK0728207T3 (da) Telomeraseaktivitetsassays
GB2343248B (en) Optical measurement of fluid samples
CA2142868A1 (en) Chemical and microbiological test kit
DK0924784T3 (da) CO-ufølsom anodekatalysator til brændselsceller med polymerelektrolyt-membraner samt fremgangsmåde til fremstilling deraf
ES2035317T3 (es) Un metodo para la deteccion y el analisis de celulas hematopoyeticas en una muestra.
DE69103420D1 (de) Selbstständige testanordnung.
MX9300494A (es) Metodo para la deteccion genetica de organismos, agentes infecciosos o componentes de una celula u organismo en una muestra biologica.
DE3782730D1 (de) Dichtungsstruktur fuer eine elektrochemische zelle.
DK614786D0 (da) Forseglingsmaerkat til en elektrokemisk metal-luft-celle
NO854448L (no) Sv40 ekspresjonsvektor inneholdende hbxag som en ekspresjonsmarkoer.
PT88615A (pt) Equipamento e metodo de dosagem imunometrica aplicavel a celulas completas
ATE227996T1 (de) Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
PT1248852E (pt) Metodo de avaliacao de viabilidade de uma celula
ATE329015T1 (de) Enzyme mit s-adenosyl-l-homocystein-hydrolase- ähnlicher aktivität.
SE9704935D0 (sv) Analysmetod med partiklar
ES8706966A1 (es) Metodo de ensayar muestras de fluido en cuanto a la presencia de anticuerpos contra un microorganismo y dispositivo correspondiente
DE59403729D1 (de) Testpflaster zur epicutanen hauttestung
ES2121756T3 (es) Analisis enzimatico y equipo de analisis para medir la activacion celular.
ATE253224T1 (de) Nachweis von zellen mittels spezifischer zellwand-bindender domänen (cbd) von zellwand-bindenden proteinen
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
WO2003058251A3 (en) Toxicity test
WO2001002599A3 (en) Assay method to identify s-phase cells on cell sections or permeabilised cells and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition